[DPHARMA] QoQ Quarter Result on 30-Sep-2017 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- 18.15%
YoY- 79.86%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 123,991 133,259 112,253 115,379 117,049 120,994 74,033 41.16%
PBT 12,915 13,255 12,825 14,207 12,642 11,176 6,299 61.60%
Tax -2,576 -2,608 -1,057 -3,080 -3,001 -2,558 2,532 -
NP 10,339 10,647 11,768 11,127 9,641 8,618 8,831 11.11%
-
NP to SH 10,339 10,782 11,870 11,405 9,653 8,618 8,428 14.63%
-
Tax Rate 19.95% 19.68% 8.24% 21.68% 23.74% 22.89% -40.20% -
Total Cost 113,652 122,612 100,485 104,252 107,408 112,376 65,202 44.98%
-
Net Worth 209,983 206,429 479,809 474,230 463,071 463,071 454,703 -40.33%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 4,199 - 16,737 - 6,973 - 11,158 -47.96%
Div Payout % 40.62% - 141.01% - 72.25% - 132.40% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 209,983 206,429 479,809 474,230 463,071 463,071 454,703 -40.33%
NOSH 650,902 278,959 278,959 278,959 278,959 278,959 278,959 76.19%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 8.34% 7.99% 10.48% 9.64% 8.24% 7.12% 11.93% -
ROE 4.92% 5.22% 2.47% 2.40% 2.08% 1.86% 1.85% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 44.29 47.77 40.24 41.36 41.96 43.37 26.54 40.82%
EPS 1.59 3.82 4.22 3.99 3.46 3.43 3.41 -39.95%
DPS 1.50 0.00 6.00 0.00 2.50 0.00 4.00 -48.09%
NAPS 0.75 0.74 1.72 1.70 1.66 1.66 1.63 -40.48%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 12.88 13.84 11.66 11.99 12.16 12.57 7.69 41.16%
EPS 1.07 1.12 1.23 1.18 1.00 0.90 0.88 13.96%
DPS 0.44 0.00 1.74 0.00 0.72 0.00 1.16 -47.69%
NAPS 0.2181 0.2144 0.4984 0.4926 0.481 0.481 0.4723 -40.34%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 1.30 2.80 2.53 2.20 2.25 2.31 1.98 -
P/RPS 2.94 5.86 6.29 5.32 5.36 5.33 7.46 -46.33%
P/EPS 35.20 72.44 59.46 53.81 65.02 74.77 65.54 -34.00%
EY 2.84 1.38 1.68 1.86 1.54 1.34 1.53 51.20%
DY 1.15 0.00 2.37 0.00 1.11 0.00 2.02 -31.38%
P/NAPS 1.73 3.78 1.47 1.29 1.36 1.39 1.21 26.99%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 26/11/18 28/05/18 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 -
Price 1.08 3.35 2.97 2.20 2.03 2.32 2.23 -
P/RPS 2.44 7.01 7.38 5.32 4.84 5.35 8.40 -56.23%
P/EPS 29.25 86.67 69.80 53.81 58.66 75.10 73.81 -46.13%
EY 3.42 1.15 1.43 1.86 1.70 1.33 1.35 86.15%
DY 1.39 0.00 2.02 0.00 1.23 0.00 1.79 -15.55%
P/NAPS 1.44 4.53 1.73 1.29 1.22 1.40 1.37 3.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment